Pieters R - Search Results

1

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: pieters r. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

2

Drug sensitivity assays in leukaemia and lymphoma.

Veerman AJ, Pieters R. Veerman AJ, et al. Among authors: pieters r. Br J Haematol. 1990 Apr;74(4):381-4. doi: 10.1111/j.1365-2141.1990.tb06323.x. Br J Haematol. 1990. PMID: 2189486 Review. No abstract available.

3

In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.

Klumper E, Ossenkoppele GJ, Pieters R, Huismans DR, Loonen AH, Rottier A, Westra G, Veerman AJ. Klumper E, et al. Among authors: pieters r. Br J Haematol. 1996 Jun;93(4):903-10. doi: 10.1046/j.1365-2141.1996.d01-1742.x. Br J Haematol. 1996. PMID: 8703824

4

Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?

Broxterman HJ, Sonneveld P, Pieters R, Lankelma J, Eekman CA, Loonen AH, Schoester M, Ossenkoppele GJ, Löwenberg B, Pinedo HM, Schuurhuis GJ. Broxterman HJ, et al. Among authors: pieters r. Leukemia. 1999 Feb;13(2):258-65. doi: 10.1038/sj.leu.2401331. Leukemia. 1999. PMID: 10025900

5

Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia.

Den Boer ML, Pieters R, Kazemier KM, Janka-Schaub GE, Henze G, Creutzig U, Kaspers GJ, Kearns PR, Hall AG, Pearson AD, Veerman AJ. Den Boer ML, et al. Among authors: pieters r. Br J Haematol. 1999 Feb;104(2):321-7. doi: 10.1046/j.1365-2141.1999.01189.x. Br J Haematol. 1999. PMID: 10050715 Free article.

6

Glutathione in childhood acute leukaemias.

Kearns P, Pieters R, Rottier MM, Veerman AJ, Schmiegalow K, Pearson AD, Hall AG. Kearns P, et al. Among authors: pieters r. Adv Exp Med Biol. 1999;457:211-6. doi: 10.1007/978-1-4615-4811-9_23. Adv Exp Med Biol. 1999. PMID: 10500796

7

Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance.

Den Boer ML, Kapaun P, Pieters R, Kazemier KM, Janka-Schaub GE, Veerman AJ. Den Boer ML, et al. Among authors: pieters r. Br J Haematol. 1999 Jun;105(4):876-82. doi: 10.1046/j.1365-2141.1999.01440.x. Br J Haematol. 1999. PMID: 10554796 Free article.

8

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. van den Heuvel-Eibrink MM, et al. Among authors: pieters r. Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110. doi: 10.5414/cpp38094. Int J Clin Pharmacol Ther. 2000. PMID: 10739113 Review.

9

Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity.

Dübbers A, Würthwein G, Müller HJ, Schulze-Westhoff P, Winkelhorst M, Kurzknabe E, Lanvers C, Pieters R, Kaspers GJ, Creutzig U, Ritter J, Boos J. Dübbers A, et al. Among authors: pieters r. Br J Haematol. 2000 May;109(2):427-9. doi: 10.1046/j.1365-2141.2000.02015.x. Br J Haematol. 2000. PMID: 10848836 Free article.

10

Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia.

Rots MG, Pieters R, Peters GJ, Noordhuis P, Van Zantwijk CH, Henze G, Janka-Schaub GE, Veerman AJ, Jansen G. Rots MG, et al. Among authors: pieters r. Br J Haematol. 2000 Jun;109(3):629-34. doi: 10.1046/j.1365-2141.2000.02071.x. Br J Haematol. 2000. PMID: 10886214 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

997 results

Search Page